NASDAQ$OLPX
OLAPLEX HOLDINGS INC · Q3 2025 earnings
Q3 2025 earnings · · Before market open · Investor relations
Briefing
Olaplex reported its third quarter 2025 financial results, showing a decrease in net sales and net income compared to the previous year, while reaffirming its annual guidance.
Olaplex experienced a challenging third quarter in 2025 with a 3.8% decrease in net sales to $114.6 million and a significant 24.8% drop in net income to $11.1 million. Despite these declines, the company reaffirmed its annual guidance, citing investments in sales and marketing, improved executional capabilities, and early positive results from new product introductions.
- Net sales for Q3 2025 decreased by 3.8% to $114.6 million compared to Q3 2024.
- Net income for Q3 2025 was $11.1 million, a 24.8% decrease from $14.8 million in Q3 2024.
- Diluted EPS remained flat at $0.02 for Q3 2025, consistent with Q3 2024.
- The company reaffirmed its fiscal year 2025 guidance for net sales, adjusted gross profit margin, and adjusted EBITDA margin.
Headline financials
Revenue & EPS history
Olaplex · Revenue · Quarterly
$115M
Revenue by segment
Olaplex · $124M total across 3 segments · Q3 2023
- Professional$48.3M-23.3%39.1%
- Specialty Retail$43.2M-41.8%35.0%
- Direct-To-Consumer$32.1M-18.3%26.0%
Forward guidance
Olaplex is reiterating its fiscal year 2025 guidance for net sales, adjusted gross profit margin, and adjusted EBITDA margin, reflecting management's expectations for investments, innovation, and execution, while considering the current consumer spending environment and earlier-than-expected Q3 shipments.
Tailwinds
- Reaffirming annual guidance for net sales, adjusted gross profit margin, and adjusted EBITDA margin.
- Continued investment in research and development to strengthen the innovation pipeline.
- Ongoing investment in marketing and talent to generate demand.
- Focus on strengthening execution capabilities.
- Early results from latest new product introductions are positive.
Headwinds
- Current consumer spending environment is a factor in guidance.
- Earlier-than-expected shipments benefited third quarter sales, potentially impacting future quarters.
- Assumes no material impact from tariffs, which could change.
- Adjusted EBITDA Margin guidance for 2025 is 20% to 22%, significantly lower than 30.7% actual in 2024.
- Net Sales guidance range of $410-$431 million for 2025 is lower than 2024 actual of $423 million at the midpoint.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q3 2025
-0.7%
Avg return
Earnings day
+0.0%
Avg return
5 days after
+7.1%
Avg return
30 days after
43%
10 / 23 earnings
Positive
+24.6%
Q3 2023
Best reaction
-21.6%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.2% | -0.2% | — | |
| Q4 2025 | -17.0% | -27.0% | +14.0% | |
| Q3 2025 | +1.9% | +7.5% | +17.9% | |
| Q1 2025 | +3.0% | -3.8% | -1.5% | |
| Q4 2024 | +21.7% | +10.9% | -15.6% | |
| Q3 2024 | -4.5% | -5.0% | +19.6% | |
| Q2 2024 | -0.5% | +0.0% | +24.3% | |
| Q1 2024 | +15.0% | +8.6% | +27.1% | |
| Q4 2023 | -5.7% | -3.1% | -0.5% | |
| Q3 2023 | +24.6% | +26.1% | +83.3% | |
| Q2 2023 | -21.6% | -27.2% | -31.4% | |
| Q1 2023 | -10.6% | -11.8% | -6.3% | |
| Q4 2022 | -15.3% | -14.0% | -24.4% | |
| Q3 2022 | +13.8% | +26.9% | +20.7% | |
| Q2 2022 | -9.7% | -4.8% | -25.9% | |
| Q1 2022 | +6.2% | +16.0% | +25.3% | |
| Q1 2021 | +6.2% | +16.0% | +25.3% | |
| Q1 2020 | +9.2% | +2.9% | +6.8% | |
| Q4 2021 | +9.2% | +2.9% | +6.8% | |
| Q2 2021 | -10.4% | -5.2% | -2.2% | |
| Q3 2021 | -10.4% | -5.2% | -2.2% | |
| Q4 2020 | -10.4% | -5.2% | -2.2% | |
| Q3 2020 | -10.4% | -5.2% | -2.2% | |
| Q2 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro